News + Filings Holdings
All 13F 13D/G Other
|
BAM Opportunity Fund, L.P.
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
01/30/2012 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
01/30/2012 |
SC 13G/A
| MELA SCIENCES, INC. reports a 0% stake in MELA Sciences, Inc. |
01/30/2012 |
SC 13G/A
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend] |
01/14/2011 |
SC 13G/A
| BAM Opportunity Fund, L.P. reports a 9.4% stake in Boise Inc. |
01/13/2011 |
SC 13G/A
| BAM Opportunity Fund, L.P. reports a 9.3% stake in Soligenix, Inc. |
01/12/2011 |
SC 13G/A
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend] |
01/07/2011 |
SC 13G/A
| MEDIVATION, INC. reports a 0.3% stake in Medivation, Inc. |
01/06/2011 |
SC 13G/A
| BAM Opportunity Fund, L.P. reports a 4.1% stake in Prana Biotechnology Limited |
08/20/2010 |
SC 13G/A
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend] |
05/19/2010 |
SC 13G/A
| BAM Opportunity Fund, L.P. reports a 9.9% stake in Medivation, Inc. |
05/19/2010 |
SC 13G/A
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend] |
05/18/2010 |
SC 13G/A
| BAM Opportunity Fund, L.P. reports a 6.2% stake in Prana Biotechnology Limited |
05/18/2010 |
SC 13G/A
| BAM Opportunity Fund, L.P. reports a 7.4% stake in Soligenix, Inc. |
03/04/2010 |
SC 13G/A
| BAM Opportunity Fund, L.P. reports a 9.9% stake in Prana Biotechnology Limited |
02/19/2010 |
SC 13G/A
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend] |
02/19/2010 |
SC 13G/A
| BAM Opportunity Fund, L.P. reports a 10.3% stake in Prana Biotechnology Limited |
01/26/2010 |
SC 13G/A
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend] |
01/25/2010 |
SC 13G/A
| BAM Opportunity Fund, L.P. reports a 9% stake in Medivation, Inc. |
01/19/2010 |
SC 13G/A
| BAM Opportunity Fund, L.P. reports a 0.1% stake in Vanda Pharmaceuticals Inc. |
01/13/2010 |
SC 13G/A
| GENTA INC DE reports a 3.2% stake in Genta Incorporated |
01/13/2010 |
SC 13G/A
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend] |
01/12/2010 |
SC 13G/A
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend] |
01/12/2010 |
SC 13G/A
| BAM Opportunity Fund, L.P. reports a 5.3% stake in Soligenix, Inc. |
01/11/2010 |
SC 13G/A
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend] |
01/11/2010 |
SC 13G/A
| BAM Opportunity Fund, L.P. reports a 3.1% stake in Emisphere Technologies, Inc. |
01/08/2010 |
SC 13G/A
| BAM Opportunity Fund, L.P. reports a 5% stake in Oculus Innovative Sciences, Inc. |
01/08/2010 |
SC 13G/A
| BAM Opportunity Fund, L.P. reports a 5% stake in Genvec, Inc. |
01/07/2010 |
SC 13G/A
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend] |
01/07/2010 |
SC 13G/A
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend] |
01/07/2010 |
SC 13G/A
| BAM Opportunity Fund, L.P. reports a 1.8% stake in BioSante Pharmaceuticals, Inc. |
01/06/2010 |
SC 13G/A
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend] |
01/06/2010 |
SC 13G/A
| BAM Opportunity Fund, L.P. reports a 11.1% stake in Prana Biotechnology Limited |
01/06/2010 |
SC 13G/A
| DARA BioSciences, Inc. reports a 0.5% stake in DARA BioSciences, Inc. |
01/05/2010 |
SC 13G/A
| REPROS THERAPEUTICS INC. reports a 0.1% stake in Repros Therapeutics Inc. |
|
|
|